Aarti Drugs Ltd AARTIDRUGS-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 9:25 AM IST
682.80quote price arrow down-8.55 (-1.24%)
Volume
112,915
52 week range
105.25 - 1,026.95

...

Loading . . .

KEY STATS

  • Open694.20
  • Day High697.90
  • Day Low675.05
  • Prev Close691.35
  • 52 Week High1,026.95
  • 52 Week High Date10/08/20
  • 52 Week Low105.25
  • 52 Week Low Date03/23/20
  • Market Cap796.74M
  • Shares Out93.2M
  • 10 Day Average Volume416,557.2
  • Dividend2.50
  • Dividend Yield0.37%
  • Beta
  • 1 Year % Change303.22

RATIOS/PROFITABILITY

  • EPS (TTM)30.93
  • P/E (TTM)22.07
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/03/2020
  • Div Amount2.50
  • Split Date-
  • Split Factor-

Latest Aarti Drugs Ltd News

There is no recent news for this security.

Latest AARTIDRUGS-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Aarti Drugs Limited is a pharmaceutical company. The Company offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins. Its products under APIs include Aceclofenac, Diclofenac Potassium, Diclofenac Diethylamine, Clopidogrel Bisulphate and Telmisartan. Its pharma intermediates include Antiprotozoal, Celecoxib, Antibiotic, Clopidogrel...
Prakash Patil
Chairman
Chandrakant Gogri
Non-Executive Chairman
Address
Block No1 & 12 To 16
Village Karanj, Tal Mandvi
Mumbai
400022
India